Analyzing Monoclonal Antibody (mAb) Fragments and Dimers Using Size Exclusion Chromatography (SEC)

Others | 2021 | Agilent TechnologiesInstrumentation
Consumables, LC columns, GPC/SEC
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Analyzing Monoclonal Antibody (mAbs) and mAb-Derived Therapeutics Using Native SEC-MS
Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods
Aggregate Analysis of Adeno-Associated Viruses and Virus-Like Particles in Biopharma by Liquid Chromatography
Helpful ‘Hints’ for Protein SEC Success
Helpful ‘Hints’ for Protein SEC Success
2021|Agilent Technologies|Presentations